Cryptococcosis laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
{{CMG}}
__NOTOC__
{{Cryptococcosis}}
{{Cryptococcosis}}
{{CMG}} {{AE}} {{SSK}}; {{YD}}


==Overview==
==Overview==

Revision as of 16:09, 31 December 2015

Cryptococcosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptococcosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptococcosis laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptococcosis laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptococcosis laboratory tests

CDC on Cryptococcosis laboratory tests

Cryptococcosis laboratory tests in the news

Blogs on Cryptococcosis laboratory tests

Directions to Hospitals Treating Cryptococcosis

Risk calculators and risk factors for Cryptococcosis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Serge Korjian M.D.; Yazan Daaboul, M.D.

Overview

Laboratory Findings

Detection of cryptococcal antigen (capsular material) by culture of CSF, sputum and urine provides definitive diagnosis.

Culture

  • The gold standard for diagnosing cryptococcal infection; culture is traditionally identify Cryptococcus from human body samples.
  • Blood cultures may be positive in heavy infections.

Microscopy

  • India Ink can be performed on CSF to quickly visualize Cryptococcus cells under a microscope; however, it can have limited sensitivity.
  • Histopathology for detection of narrow-based budding yeasts in tissue can also be used.

Antigen detection

  • Antigen detection can be used on CSF or serum for detection of early, asymptomatic cryptococcal infection in HIV-infected patients.
  • It has a higher sensitivity than microscopy or culture.
  • Techniques used include:
  • Latex agglutination (LA)
  • Enzyme immunoassay (EIA)
  • Lateral flow assay (LFA)

References